Savior Lifetec Corporation

Taipei Exchange 4167.TWO

Savior Lifetec Corporation Cash and Short-Term Investments for the year ending December 31, 2023: USD 43.56 M

Savior Lifetec Corporation Cash and Short-Term Investments is USD 43.56 M for the year ending December 31, 2023, a -19.06% change year over year. Cash and short-term investments are the sum of cash and short-term investments, representing the company's liquid assets.
  • Savior Lifetec Corporation Cash and Short-Term Investments for the year ending December 31, 2022 was USD 53.82 M, a 194.18% change year over year.
  • Savior Lifetec Corporation Cash and Short-Term Investments for the year ending December 31, 2021 was USD 18.29 M, a -35.86% change year over year.
  • Savior Lifetec Corporation Cash and Short-Term Investments for the year ending December 31, 2020 was USD 28.52 M, a 46.30% change year over year.
  • Savior Lifetec Corporation Cash and Short-Term Investments for the year ending December 31, 2019 was USD 19.49 M, a 29.21% change year over year.
Key data
Date Cash and Short-Term Investments Receivables Inventory Goodwill
Market news
Loading...
SV Wall Street
Taipei Exchange: 4167.TWO

Savior Lifetec Corporation

Description

Savior Lifetec Corporation, a specialty injectable company, produces and supplies sterile APIs and finished dosage formulations. The company offers imipenem and cilastatin sodium, an antibacterial agent for intravenous infusion; and meropenem, a beta-lactamase resistant carbapenem antibiotic for parenteral administration. It also provides ertapenem, a form of carbapenem for use on gram-negative and gram-positive anaerobes and aerobic. The company's pipeline products include SLC-006 for prostate cancer endometriosis uterine leiomyoma; and sterile paliperidone palmitate API for the treatment of schizophrenia. Savior Lifetec Corporation was founded in 2004 and is headquartered in Miaoli County, Taiwan.

Similar companies

4147.TWO

TaiMed Biologics Inc.

USD 2.60

NA

4162.TWO

PharmaEngine, Inc.

USD 3.03

NA

4157.TWO

TaiGen Biopharmaceuticals Holdings Limited

USD 0.34

NA

4192.TWO

SynCore Biotechnology Co.,Ltd

USD 1.06

NA

StockViz Staff

February 4, 2025

Any question? Send us an email